ArticleScientific reports2025
Risk factors for postoperative nausea and vomiting after endovascular interventional therapy: a case-control study.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Interpretable machine learning for postoperative nausea and vomiting prediction in elderly orthopedic patients: a comparative study.BMC medical informatics and decision making · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Postoperative nausea and vomiting (PONV) remain common complications following endovascular intervention. The unique risks for patients undergoing endovascular therapy under local or monitored anaesthesia care (MAC) remain poorly characterized. To investigate the risk factors for PONV after endovascular interventional therapy. A total of 319 patients were included in this case-control study. Initially, we compared the baseline clinical and endovascular intervention characteristics of 25 patients who experienced PONV with those of 294 control patients. A multivariate logistic regression model was subsequently employed. Sex, allergic history, intervention type, and operation duration differed significantly between two groups. According to the multivariate logistic regression model, sex (female) (OR = 2.66; 95% CI: 1.04-6.84; p = 0.042), a history of allergies (OR = 6.56; 95% CI: 2.32-18.56; p < 0.001), an eGFR < 60 ml/min/1.73 m² (OR = 5.89; 95% CI: 1.99-17.49; p = 0.001), embolization (OR = 3.29; 95% CI: 1.20-8.98; p = 0.020), and an iodine contrast agent concentration > 400 ml (OR = 18.54; 95% CI: 2.38-144.28; p = 0.005) were significant risk factors for PONV. Sex (female), a history of allergies, renal insufficiency, embolization and the use of high-dose iodine contrast agents were significant risk factors for PONV after endovascular interventional therapy.Trial registration: The trial was registered online on 11th November 2024 in the Chinese Clinical Trial Registry (ChiCTR2400092672).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.